Safety and efficacy of daridorexant in patients with insomnia disorder: results from two multicentre, randomised, double-blind, placebo-controlled, phase 3 trials (vol 21, pg 125, 2022)

被引：5
|
作者：
Mignot, E.
Mayleben, D.
Fietzeet, I
机构：
来源：
LANCET NEUROLOGY | 2022年 / 21卷 / 03期
关键词：
D O I：
10.1016/S1474-4422(22)00029-1
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Safety and efficacy of teriflunomide in paediatric multiple sclerosis (TERIKIDS): a multicentre, double-blind, phase 3, randomised, placebo-controlled trial
    Chitnis, Tanuja
    Banwell, Brenda
    Kappos, Ludwig
    Arnold, Douglas L.
    Guecueyener, Kivilcim
    Deiva, Kumaran
    Skripchenko, Natalia
    Cui, Li-Ying
    Saubadu, Stephane
    Hu, Wenruo
    Benamor, Myriam
    Le-Halpere, Annaig
    Truffinet, Philippe
    Tardieu, Marc
    LANCET NEUROLOGY, 2021, 20 (12): : 1001 - 1011
  • [22] Brexanolone injection in post-partum depression: two multicentre, double-blind, randomised, placebo-controlled, phase 3 trials
    Meltzer-Brody, Samantha
    Colquhoun, Helen
    Riesenberg, Robert
    Epperson, C. Neill
    Deligiannidis, Kristina M.
    Rubinow, David R.
    Li, Haihong
    Sankoh, Abdul J.
    Clemson, Christine
    Schacterle, Amy
    Jonas, Jeffrey
    Kanes, Stephen
    LANCET, 2018, 392 (10152): : 1058 - 1070
  • [23] Efficacy and safety of trimodulin in patients with severe COVID-19: results from a randomised, placebo-controlled, double-blind, multicentre, phase II trial (ESsCOVID)
    Agafina, Alina
    Aguiar, Valeria Cristina
    Rossovskaya, Maria
    Fartoukh, Muriel Sarah
    Hajjar, Ludhmila Abrahao
    Thiery, Guillaume
    Timsit, Jean-Francois
    Gordeev, Ivan
    Protsenko, Denis
    Carbone, Javier
    Pellegrini, Rita
    Stadnik, Claudio Marcel Berdun
    Avdeev, Sergey
    Ferrer, Miquel
    Heinz, Corina C.
    Haeder, Thomas
    Langohr, Patrick
    Bobenhausen, Iris
    Schuettrumpf, Joerg
    Staus, Alexander
    Ruehle, Markus
    Weissmueller, Sabrina
    Wartenburg-Demand, Andrea
    Torres, Antoni
    EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2024, 29 (01)
  • [24] Efficacy and safety of voclosporin versus placebo for lupus nephritis (AURORA 1): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial (vol 397, pg 2070, 2021)
    Rovin, B. H.
    Teng, Y. K. O.
    Ginzler, E. M.
    LANCET, 2021, 397 (10289): : 2048 - 2048
  • [25] Efficacy and safety of voclosporin versus placebo for lupus nephritis (AURORA 1): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial
    Rovin, Brad H.
    Teng, Y. K. Onno
    Ginzler, Ellen M.
    Arriens, Cristina
    Caster, Dawn J.
    Romero-Diaz, Juanita
    Gibson, Keisha
    Kaplan, Joshua
    Lisk, Laura
    Navarra, Sandra
    Parikh, Samir V.
    Randhawa, Simrat
    Solomons, Neil
    Huizinga, Robert B.
    LANCET, 2021, 397 (10289): : 2070 - 2080
  • [26] Safety and efficacy of arimoclomol for inclusion body myositis: a multicentre, randomised, double-blind, placebo-controlled trial
    Machado, Pedro M.
    McDermott, Michael P.
    Blaettler, Thomas
    Sundgreen, Claus
    Amato, Anthony A.
    Ciafaloni, Emma
    Freimer, Miriam
    Gibson, Summer B.
    Jones, Sarah M.
    Levine, Todd D.
    Lloyd, Thomas E.
    Mozaffar, Tahseen
    Shaibani, Aziz, I
    Wicklund, Matthew
    Rosholm, Anders
    Carstensen, Tim Dehli
    Bonefeld, Karen
    Jorgensen, Anders Norkaer
    Phonekeo, Karina
    Heim, Andrew J.
    Herbelin, Laura
    Barohn, Richard J.
    Hanna, Michael G.
    Dimachkie, Mazen M.
    LANCET NEUROLOGY, 2023, 22 (10): : 900 - 911
  • [27] Safety and efficacy of metformin in systemic lupus erythematosus: a multicentre, randomised, double-blind, placebo-controlled trial
    Sun, Fangfang
    Wang, Hui Jing
    Liu, Zhe
    Geng, Shikai
    Wang, Haiting
    Wang, Xiaodong
    Li, Ting
    Morel, Laurence
    Wan, Weiguo
    Lu, Liangjing
    Teng, Xiangyu
    Ye, Shuang
    LANCET RHEUMATOLOGY, 2020, 2 (04): : E210 - E216
  • [28] Safety and efficacy of givinostat in boys with Duchenne muscular dystrophy (EPIDYS): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial (vol 23, pg 393, 2024)
    Mercuri, E.
    Vilchez, J. J.
    Boespflug-Tanguy, O.
    LANCET NEUROLOGY, 2024, 23 (06): : E10 - E10
  • [29] EFFICACY AND SAFETY OF BARICITINIB IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS: RESULTS FROM TWO RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, PHASE 3 STUDIES
    Morand, E. F.
    Tanaka, Y.
    Furie, R.
    Vital, E.
    van Vollenhoven, R.
    Kalunian, K.
    Mosca, M.
    Doerner, T.
    Wallace, D. J.
    Silk, M.
    Dickson, C.
    De la Torre, I.
    Meszaros, G.
    Jia, B.
    Crowe, B.
    Petri, M. A.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 327 - 328
  • [30] Safety and efficacy of GD-11 in patients with ischaemic stroke: a multicentre, double-blind, randomised, placebo-controlled, phase 2 trial
    Zhang, Runhua
    Liu, Gaifen
    Zhao, Xingquan
    Wang, Yilong
    Li, Zixiao
    Chen, Guofang
    Liu, Bo
    Ling, Yun
    Wang, Yongjun
    Li, Shuya
    STROKE AND VASCULAR NEUROLOGY, 2024,
12345